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Abstract
Evolutionary innovation relies partially on changes in gene regulation. While a growing body of evidence demonstrates that
such innovation is generated by functional changes or translocation of regulatory elements via mobile genetic elements,
the de novo generation of enhancers from non-regulatory/non-mobile sequences has, to our knowledge, not previously
been demonstrated. Here we show evidence for the de novo genesis of enhancers in vertebrates. For this, we took
advantage of the massive gene loss following the last whole genome duplication in teleosts to systematically identify
regions that have lost their coding capacity but retain sequence conservation with mammals. We found that these regions
show enhancer activity while the orthologous coding regions have no regulatory activity. These results demonstrate that
these enhancers have been de novo generated in fish. By revealing that minor changes in non-regulatory sequences are
sufficient to generate new enhancers, our study highlights an important playground for creating new regulatory variability
and evolutionary innovation.
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Introduction
The question of the evolutionary origin and modification of
enhancer elements is central for understanding the dynamics of
gene expression [1–3]. A growing body of evidence points out that
new enhancers evolve from existing ones via duplication.
According to the classic model of evolution by duplication as put
forward by Ohno [4], the duplicated copies are used as starting
material for variation in the binding site composition, which
modifies the respective enhancer’s activity [5–10]. Mobile genetic
elements have also been shown to have regulatory activity [11,12]
or bear transcription factor binding sites (TFBSs) [13], and thus,
their translocation can be associated with changes in gene
expression.
While the modification/translocation of those pre-existing
elements has been shown to play an important functional role,
they may only contribute to a fraction of the regulatory
innovation. Indeed, recent findings using large-scale comparative
analysis of regulatory features have shown that single binding sites
can vary extensively between closely related species [14] or even
between individuals of the same species [15]. Further supporting
the flexibility of regulatory elements, tissue-specific enhancers such
as heart enhancers have been shown to be poorly conserved [16]
and examples of lineage/specie-specific enhancers have been
described [17,18]. Recently it has been reported that the genomic
positions of tissue-specific enhancers of the yellow gene differ
between Drosophila species [19].
Taken together, these results are suggesting that complete
autonomous enhancer elements containing all the necessary
binding sites in the correct arrangement can be lineage specific.
Nevertheless it is currently unclear whether these apparent
lineage-specific enhancers appear de novo or are derived from
pre-existing enhancers whose sequences have diverged too much
to be identifiable. In order to show the de novo nature of these
lineage-specific enhancers, a strategy to identify the orthologous
regions and test them for enhancer activity is needed.
In this report we identify de novo enhancers by searching for
special cases that we refer to as ‘‘Recycled Regions’’ (RRs). An RR
is a region with enhancer function in one lineage that remains
identifiable in another lineage due to sequence constraints
imposed by a different kind of function. These scenarios are likely
to be very rare in stable genomes. Thus, we took advantage of the
most recent Whole Genome Duplication (WGD) in teleosts [20]
followed by a massive loss of the duplicated coding genes. It is
estimated that 75% of the duplicated genes lost one copy [20].
Initially, while one of the duplicated copies remained a coding
gene, the other copy lost its coding function and accumulated
nucleotide changes. In rare cases, the sequence from the non-
coding copy became constrained if a regulatory function arose de
novo. Those regulatory sequences are alignable to their coding
orthologs if the selection for the new function took place soon
enough. Hence we used the ancestral coding function as an
evolutionary trap to identify orthologous sequences of the
enhancer across lineages (mammalian, cartilaginous fish, and
teleost) and assessed whether these enhancers are generated de
novo in the teleost lineage (Figure 1A).
Results
Identification of the Recycled Regions
We developed an algorithm to systematically search for the RRs
in teleost fish genomes that satisfy the corresponding criteria
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copy of a duplicated gene; (2) despite no evidence for the coding
function, are conserved with part of the human coding ortholog;
and (3) as experimental validation is performed during embryo-
genesis, we selected those RRs flanked by at least one gene
annotated to be involved in development (Figure S1 and Materials
and Methods, Computational Pipeline). The algorithm was first
run on the stickleback (Gasterosteus aculeatus) genome because of the
high quality of the gene annotation and assembly, and later the
results were transferred to the Oryzias latipes (medaka) genome. Our
analysis identified four RRs (Figure 1C, Table S1, and Table S2)
as putative de novo regulatory regions satisfying the above criteria.
Those RRs are conserved across teleosts including Danio rerio
(zebrafish), suggesting that they appear after the WGD but before
the Cypriniformes-Euteleostei split.
The Recycled Regions Show Enhancer Activity
We investigated the enhancer activity of the four medaka RRs
(Figure 1C and Table S1) using an in vivo reporter assay in
medaka that we previously developed [21]. We cloned the four
RRs extended with a maximum of 200 bp flanking sequences
upstream of an hsp70 minimal promoter and a reporter gene (gfp).
The basal expression of the hsp70 minimal promoter in the lens
[22] was used as injection control. We found that all four regions
tested drive reporter gene expression in specific structures in the
medaka embryo (Figure 2A–D). The assay is highly reproducible,
resulting in a consistent expression pattern in a large fraction of
embryos (Table S3). The onset of reporter gene expression
depends on the nature of the RR and varies from developmental
stage 20 (fam44b
RR) to stage 32 (dock9
RR) and is in all cases
maintained in juvenile (Figure S2) and adult fish (unpublished
data). Moreover, the specific expression pattern observed in
injected embryos (Table S3) is retained in stable lines. In line with
our hypothesis, these results show enhancer activity for all four RR
reporter constructs. We further addressed the contribution of the
four RRs to the observed enhancer activity by deleting the
orthologous regions corresponding to the exon, leaving only the
flanking regions from the reporter constructs (Figure S3A–D). In
two cases, the deletion constructs completely abolished reporter
gene expression (Figure S3E–F). For ccdc46
RR, the deletion
altered and massively reduced the reporter gene expression to a
few cells in the hindbrain (Figure S3G). Only for fam44b
RR did
the deletion construct not abolish the original enhancer activity of
the full construct (Figure S3H) and therefore fam44b
RR was
excluded from further analysis. These results demonstrate that
three out of four RRs are necessary for enhancer activity.
Recycled Regions Recapitulate Part of the Flanking Gene
Expression Patterns
We next investigated whether the enhancer activity of the
remaining three RRs recapitulates aspects of the expression
pattern of flanking genes. For this, we analysed the in situ
expression pattern of those genes. We found that in all cases RR-
driven reporter gene expression temporally and spatially resembles
the expression of at least one of the respective flanking genes
(Figure S4). To further confirm this, we performed double
fluorescent whole mount in situ hybridisation on stable transgenic
lines by combining probes for the reporter and the flanking genes.
In all cases, we identified at least one flanking gene that
recapitulates key aspects of the expression pattern of the RR-
driven reporter gene (Figure 3). In particular, both ttc29
RR-driven
GFP (Figure 3B) and the flanking gene pou4f2 (Figure 3A) are
expressed in the optic tectum and retina (Figure 3C). dock9
RR
shows very specific enhancer activity in the cerebellum
(Figure 3E,H) as do the neighbouring genes zic5 and zic2
(Figure 3D,G), which exhibit an expression pattern that includes
the cerebellum (Figure 3F,I). Finally, ccdc46
RR shows activity in
the forebrain (Figure 3K), recapitulating part of the expression
pattern of its flanking gene axin2 (1 of 2) (Figure 3J,L). All putative
target genes have been reported to play important roles in
developmental processes: Zic2 and 5 are zinc finger proteins of the
cerebellum, and mutations in the zic2 gene have been reported to
cause holoprosencephaly [23]. Axin2, an Axin-related protein, has
been shown to play an important role in the regulation of b-
catenin stability in the Wnt signalling pathway [24], and Pou4f2,
better known as Brn3b, is a member of the POU-domain family of
transcription factors and is a key regulator for axon outgrowth and
pathfinding in projection neurons [25]. Our results demonstrate
that the RRs exhibit enhancer activity that recapitulates multiple
aspects of the expression of neighbouring genes. Our results
further suggest that the identified RRs contribute to the
transcriptional regulation of genes that are key players in
embryonic development.
Two possible evolutionary scenarios may account for our results
obtained so far: (1) the ancestral function was both regulatory and
coding or (2) the ancestral vertebrate sequence was coding but the
teleosts have lost that function in one of the duplicated copies and
acquired regulatory function instead (which supports the de novo
enhancer hypothesis). For the former scenario, dual functions on
the same region have been hypothesised [26] and shown for
several cases [27–32] while the latter scenario has not been shown
so far. To shed light on the ancestral state of the RRs, we
investigated the RRs in lineages that diverged prior to the last
WGD in teleosts.
Orthologous Regions in Non-Teleost Lineages Show No
Enhancer Activity
In species that have diverged prior to the teleost-tetrapod split
(e.g., elephant shark (Callorhinchus milii) or ciona (Ciona savignyi)) the
sequences corresponding to the three RRs showed an open
reading frame (ORF) spanning the coding exon that is in frame
Author Summary
The genome of each living organism contains thousands
of genes, and the precise control of the timing and
location of expression of these genes is key for normal
development and homeostasis of each individual. Despite
the oftentimes high genetic similarity between organisms,
the source of phenotypic differences, for example between
human and mouse, is thought to originate mainly from
changes in how and when genes are expressed. This is
partially determined by enhancers, that contribute to the
control of gene expression. For decades, duplication of
existing genomic enhancers, mobile elements, and chang-
es in the sequence of existing enhancers were believed to
be the major ways of increasing the number and
modifying the activity of enhancers. In this study, we
show that enhancers don’t have to be derived from pre-
existing ones but can also appear de novo in regions of the
genome that were previously not regulating gene
expression. We analyzed teleost fish genomes and found
three regions for which a limited number of changes in the
DNA sequence was sufficient to generate new enhancers.
We predict that such a process is frequent in vertebrate
genomes, making de novo generation of enhancers an
important mechanism for creating variation in gene
expression.
De Novo Vertebrate Enhancers
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we also found EST evidence in the ciona lineage (Table S2). These
results show that the RRs ancestral sequences were very likely to
have been coding at the split of the teleost-tetrapod lineages.
We next investigated the evolutionary dynamics of these regions
by analysing the similarity between the human coding exon and
the orthologous regions in various lineages at both the amino-acid
(AA) and nucleotide level. We found that the percentage identity at
Figure 1. Using an evolutionary trap to identify de novo enhancer sequences. (A) After Whole Genome Duplication (WGD) in teleost fish,
one copy of an ancestrally coding sequence lost its coding function and acquired a regulatory function instead (blue branch). The sequence is
retained in the fish genome because of the selection acting on the new function while the orthologous sequences in mammalian and shark are
retained because of the coding function (red branches). If the gain of the regulatory activity happened sufficiently fast after the loss of the coding
function, all sequences (human, fish, and shark) can be detected using standard alignment algorithms. Thus, the de novo nature of the regulatory
function in fish is addressable. The evolutionary time since the divergence from the last common ancestor is taken from [35] and [63]. (B) Schematic
example of an evolutionary scenario leading to the appearance of de novo enhancers: The recycled locus (RL) in fish has lost the gene (red), but one
region (blue) in the RL is still alignable to one human exon. This region we refer to as a ‘‘Recycled Region’’ (RR) and is a good candidate for having a
de novo acquired regulatory function controlling the expression of the neighbouring gene (orange). The approach used to identify such a scenario is
described in Figure S1, Materials and Methods and Computational Pipeline. (C) Schematic overview of human loci and both duplicated loci in medaka
for all candidate RRs: As in (B), the human gene corresponding to the RR is shown in red, the medaka RR is shown in blue. The putative target gene(s)
of the RR is in orange. For ttc29
RR the homologous coding sequence was not found in medaka. The presence of two intact dock9 genes in medaka is
likely the result of an additional duplication unrelated to the WGD in fish. Only genes flanking the RR and their orthologs are shown. For clarity, all
genes (except for the red genes) are shown as two exon genes, even though they may contain more exons. Gene names written above the schematic
representation indicate the location on the ‘‘plus’’ strand, names written below indicate location of the gene on the ‘‘minus’’ strand. The distances
between genes do not reflect the actual genomic distances.
doi:10.1371/journal.pbio.1001188.g001
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at the AA level is higher for all other lineages, including the fish
coding paralog (Figure S6). Consistent with the alignment
similarities, the ratio of non-synonymous compared to synony-
mous base pair changes (Ka/Ks) [33] is increased for the RRs
compared to the coding homologs (see Materials and Methods and
Figure S6). In accordance with the results obtained so far, these
data further support the hypothesis that (1) the RRs were
ancestrally coding and (2) the fish RRs are under a selection
acting at the nucleotide rather than at the AA level. These data
suggest that the RRs were ancestrally not regulatory since the Ka/
Ks ratio between human and shark or ciona would favour a
selection acting at the AA level only.
To test the nature (regulatory or non-regulatory) of the ancestral
state at the tetrapod-teleost split, we further explored the enhancer
activity of the exons homologous to the RRs in two independent
lineages (mouse and elephant shark) as well as the coding paralog
in fish (Figure 4).
In none of the cases tested was an enhancer activity detectable
(Figure 4 and Table S3). As the exon orthologous to the RRs was
tested in the Medaka embryo, the absence of activity could be due
to trans-regulatory changes [34]. To rule out this hypothesis, the
mouse exons orthologous to the RRs were tested directly in mouse.
Again, in none of the cases tested was an enhancer activity
detectable (Figure 4 and Material and Methods), confirming that
the mouse exons orthologous to the RRs have no enhancer activity
(at the time point assayed).
The results obtained so far provide convincing evidence that the
enhancer function in teleosts was de novo acquired in this lineage.
As most of the de novo genesis of enhancers is expected to occur in
‘‘neutrally’’ evolving sequences, these cases of de novo enhancers
deriving from cooption may constitute a very small subset of all
possible de novo enhancers.
We roughly estimate at several thousands the number of de
novo enhancers under positive selection since the tetrapod-teleost
split (450 mya [35], see Text S1 and Figure S7 for a more detailed
analysis of the estimation of the number of de novo enhancers).
Considering that those de novo elements under purifying selection
mayconstitute onlya tinyfractionofall possibleregulatoryelements
generated, the rate of genesis of new enhancers (regardless of their
evolutionary fate) may be very high in vertebrate genomes. While
this estimation of the number of de novo enhancers is only tentative
and based on a number of assumptions (see Text S1), a more
accurate prediction of the de novo enhancers across various
phylogenetic branches of vertebrates will require further studies.
Nonetheless, these results highlight the importance of the genesis of
enhancers and provide one possible explanation amongst others of
the widespread observation that a large fraction of TFBSs appears
non-conserved [36]. Nonetheless, those TFBSs forming de novo
enhancers may represent only a fraction of all the apparent lineage-
specific binding sites found by genome-wide chromatin immuno-
precipitation experiments.
In an attempt to predict what the possible TFBS involved in the
generation of the de novo enhancers are, we further investigated at
Figure 2. The Recycled Regions (RRs) show enhancer activity in medaka. Expression of the reporter gene GFP under the control of the RRs
(6 flanking 200 bp) in stable transgenic embryos. Confocal images of medaka stage 32 embryos (dorsal view, anterior to the left). (A) ttc29
RR::GFP
construct: The reporter gene can be detected in the retina (re) and in the optic tectum (ot) when driven by the ttc29
RR. The lens expression is
attributed to the activity of the hsp70 minimal promoter (see Methods). (B) dock9
RR::GFP construct: The reporter gene can be detected in the
cerebellum (ce) and cells in the optic tectum (ot). (C): ccdc46
RR::GFP construct: The reporter gene can be detected in fore- and hindbrain (fb/hb). (D)
fam44b
RR::GFP construct: The reporter gene can be detected in multiple structures of the brain, including forebrain (fb), optic tectum (ot), and
hindbrain (hb).
doi:10.1371/journal.pbio.1001188.g002
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between the RRs and the exons (Materials and Methods). We
found from five to seven binding sites in the medaka RRs that are
specific to teleosts and are not present in other vertebrate species
nor in the predicted ancestral reconstruction (Figure S8).
Interestingly, dock9
RR in medaka (with enhancer activity in the
cerebellum) has a new binding site for Pax2, a transcription factor
known to be involved in cerebellum development [37].
Function of the De Novo Enhancers in Gene Regulation
These de novo enhancers may either confer additional
domains of expression to their target genes or rather act as
redundant enhancers. To tackle the functional consequences of
the de novo enhancers, we took advantage of a conserved block
flanking the ccdc46
RR homologous exon previously shown to be
bound by p300 in mouse forebrain (Figure S9, orange bar, upper
panel) [38]. We tested the mouse extended region containing
both the p300 pulldown region and the extended exonic sequence
(Figure S9, light green bar, upper panel) and detected enhancer
activity in the medaka forebrain (Figure S9A). This activity was
not altered when deleting the exonic sequence (Figure S9, blue
bar, upper panel and Figure S9B), demonstrating that the exon
itself is not required for enhancer function (see also Figure 4).
Similarly, the shark and medaka sequences (Figure S9, orange
Figure 3. Enhancer activity of the RRs recapitulates key aspects of the neighbouring gene expression pattern. Double-fluorescent
whole-mount in situ hybridisation of candidates. The mRNA of the putative target gene was visualised using Fast Red staining (A, D, G, J shown in red
in the merged images). GFP mRNA driven by the RRs was detected using TSA-fluorescein (B, E, H, K shown in green in the merged images). Confocal
images of medaka stage 32 embryos (dorsal view, anterior to the left). (A–C) Expression of pou4f2 mRNA is detected in the optic tectum (ot) and the
hindbrain (hb) (A) while ttc29
RR drives GFP mRNA expression in a subset of cells in the optic tectum (ot) (B). Both expression patterns overlap in the
optic tectum (ot) (C). (D–F) Expression of zic2 mRNA is detected in the optic tectum (ot) and the cerebellum (ce) (D) while dock9
RR drives GFP mRNA
expression specifically in the cerebellum (ce) (E). Both expression patterns overlap in the cerebellum (ce) (F). (G–I) Expression of zic5 mRNA is detected
in the cerebellum (ce) (G) while dock9
RR drives GFP mRNA expression in the cerebellum (ce) (H). Both expression patterns overlap in the cerebellum
(ce) (I). (J–L) Expression of axin2 (1 of 2) mRNA is detected in the forebrain (fb) (J), as well as for the GFP expression under the control of ccdc46
RR (K).
Both expression patterns overlap in the anterior part of the forebrain (L).
doi:10.1371/journal.pbio.1001188.g003
De Novo Vertebrate Enhancers
PLoS Biology | www.plosbiology.org 5 November 2011 | Volume 9 | Issue 11 | e1001188bar, lower panel) orthologous to the mouse p300-bound enhancer
also show forebrain activity (Figure S9C–D). These results
demonstrate that the p300-bound enhancer element is an
ancestral feature and suggest that the nearby ccdc46
RR de novo
enhancer in fish has complementary function to reinforce the
forebrain expression rather than creating a new expression
domain. Similarly dock9
RR is active in the medaka cerebellum,
while the mouse zic2 and 5 genes are also expressed in this
structure [39].
While those de novo enhancers may still quantitatively modify
the transcript level within the cell or activate transcription in
related cell types within the same domains, these results favour the
hypothesis of redundant enhancer. This hypothesis is supported by
the recent finding that redundant enhancers confer phenotypic
robustness [40,41] and thus are likely to be selected for.
Similar to TFBS turnover by the de novo emergence of new
binding sites [42], complete enhancers may also be turned over,
leading to the disappearance of the ancestral element.
Discussion
It has long been thought that new functions emerge primarily by
duplication and/or modification ofexisting functional elements[43].
On the gene level, this view has begun to change with the recent
publication of several studies reporting the de novo origin of genes in
yeast [44], drosophila [45], and human [46]. In this study we show
that not only genes but also enhancers can be de novo generated.
De novo genesis of enhancers raises the question of how
evolution can produce such complex functional elements. Indeed,
enhancers were generally believed to have a stringent regulatory
code, and thus the odds for generating a de novo enhancer were
believed to be low. Recent studies have already started challenging
that view by pointing either to the flexibility of this code [18,47] or
the rapid turnover of binding sites [14,15,42]. It is possible that the
appearance of new binding sites can not only modify pre-existing
enhancer but also lead to the creation of completely new
autonomous enhancers.
This work further shows the relative ‘‘facility’’ of conferring
regulatory activities to non-regulatory sequences. Consequently,
the birth of regulatory elements is a highly dynamic property of
vertebrate genomes and should also be considered as an
evolutionary toolkit for innovation. The results of this study have
significant implications, notably in the gene regulation and
medical genetic fields by pointing out that genomic variation
could lead to the generation of enhancers in regions with no
apparent regulatory function. As such variation may also lead to
altered gene expression, more attention should be devoted to
variation in so-called ‘‘neutral’’ DNA.
Figure 4. The coding homologs of the RRs show no enhancer activity. The coding homologs of the RRs in medaka (column 2), mouse
(column 3), and elephant shark (column 4) show no enhancer activity. For clarity, we included the result of enhancer activity of the RR regions
(column 1). For ttc29
RR no homologous coding sequences were found in medaka and shark. While only one stage is represented, the monitoring of
the reporter gene expression is performed throughout the embryonic development (except for the mouse transgenic assay where the specific stage
is annotated on the figure). For dock9
exon-medaka, both exons from both paralogs were tested (Table S3). Branch lengths and loci are schematic.
doi:10.1371/journal.pbio.1001188.g004
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Computational Pipeline
Summary of the computational pipeline. In order to find
RRs we undertook a conservative analysis of the stickleback non-
coding genomic sequences mapping to the human exome. For this,
a total of 282,599 human annotated exons were mapped to the
stickleback genome using BLASTZ. BLASTZ is a sensitive
alignment tool suited for non-coding genomic sequences. In
order to retain only the stickleback non-coding regions, hits
matching even partially an annotated exon in stickleback were
removed. To identify putative RRs we took advantage of the last
WGD in teleosts followed by the massive loss of the duplicated
genes. Only hits in the syntenic loci between human and
stickleback were further processed. From the WGD, two such
syntenic loci per human locus can be found in fish (one locus
contains the functional protein, while the other locus has lost the
gene). Thus we restrict the search to only hits containing stop
codon(s) disrupting the ORF and found in the locus of the lost
gene. Such hits are good candidates for having acquired a de novo
enhancer function controlling nearby genes. As experimental
validation is performed during embryogenesis, we further selected
those hits flanked by at least one gene annotated to be involved in
development (Figure 1B and Figure S1).
We identified four BLASTZ hits on the stickleback genome as
putative RR candidates and transferred the hits to the medaka
genome (Figure 1C and Table S1) for experimental validation.
Human exons. The repeat-masked DNA sequences of a total
of 282,599 human annotated exons (length .19 bp for BLASTZ)
were retrieved from EnsEMBL v. 49 [48].
Alignment with stickleback (Gasterosteus aculeatus). DNA
sequences corresponding to the human (Homo sapiens)e x o n sw e r e
matched to the repeat-masked stickleback genome (EnsEMBL v. 49)
using BLASTZ (default parameters, score above 2,900) [49]. A total of
145,095 human exons (51%) have at least one BLASTZ hit on the
stickleback genome. This number corresponds to 24,214 human
genes. The average BLASTZ score is 5,220. The average number of
hits on the stickleback genome is 7.3 hits per conserved exon. For each
exon, hits on the stickleback genome within 1 kb from each other are
considered to be part of the same regulatory unit and were therefore
fused. To deplete the dataset from un-annotated genes or exons, only
exons from human genes with at least one annotated ortholog in
stickleback were further considered. Any hits within 2 Mb of the
stickleback ortholog(s) locus were removed. Alignments matching even
partially an annotated exon or EST in stickleback or any other
sequenced teleosts (EnsEMBL gene annotation) were also removed.
Synteny assessment. All the neighbouring developmental
genes (see section below) within a 300 kb window upstream and
downstream of the human exon were retrieved. Next, the positions
of the corresponding orthologs in stickleback were compared with
all the positions of the BLASTZ hits. If one hit is less that 100 kb
away from the identified orthologs and no more than five genes
are located in between, the hit is retained. To remove false
positives due to un-annotated genes, if more than one hit per gene
is found within a window of 300 kb, all the hits are discarded.
GO filtering. We define developmental genes as genes with the
following GO annotation: GO:0045165 (cell fate commitment),
GO:0032502 (developmental process), GO:0030528 (transcription
regulator activity), and GO:0003700 (transcription factor activity)
as well as the descendant annotations as defined by the Open
Biomedical Ontologies (version 1.2) [50].
Assessment of reading frames. The nucleotide regions on
the stickleback genome corresponding to the BLASTZ hits were
aligned to the corresponding human exon using BLASTx. If the
resulting alignment span of the entire stickleback region within one
frame and no stop codon can be found, the region is discarded.
Bioinformatic Analysis of the Candidate RR
Assessment of reading frames. Using the human exon
coordinates (Table S1), we retrieved the 46-way multiz hg19
alignments for mouse (Mus musculus), chicken (Gallus gallus), and
xenopus (Xenopus tropicalis). Missing sequences (medaka (Oryzias
latipes), ciona (Ciona savignyi)) were retrieved using EnsEMBL v.49,
and the orthologous sequences from elephant shark (Callorhinchus
milii) were retrieved using the homepage of the elephant shark
genome project (http://esharkgenome.imcb.a-star.edu.sg) [51]. If
no orthologous exon was annotated, tBLASTn was used to
retrieve the corresponding regions. The sequences were translated
in the reading frame corresponding to the human exon, and an
alignment of the orthologous AA sequences was performed
(CLUSTALW). For DOCK9 the 59UTR was removed in all
species analysed. The human TTC29 exon extends over two exons
in the ciona lineage; thus the coding sequence of both ciona exons
was fused to do the translation. In medaka, no ttc29 gene could be
found.
Multiple alignments, percentage identity/similarity, and
Ka/Ks. Sequences were retrieved as described above. The
sequences missing from the multiz alignments were added
subsequently by global alignment (cost matrix 65% similarity
(5.0/24.0), gap open/extension penalty: 12/3). The percentage
identity/similarity to the human exon sequence was calculated
using the alignments from pairwise BLASTn (for the nucleotide
identity, default parameters) and tBLASTx (for the AA similarity,
word size parameter set to 2). Percentages were calculated using
the alignable length of the human exon as reference. The Ka/Ks
ratio [33] was calculated using the alignable length of the human
exon as reference sequence. Because the RRs contain elements
that disrupt the ORF (see Assessment of Reading Frames), indels
and stop codons were removed prior to calculating the Ka/Ks.
Calculations were done using the PAML package included in the
PAL2NAL tool of the Bork-Group at EMBL (http://www.bork.
embl.de/pal2nal/#RunP2N) [52].
Ancestral reconstruction and TFBS composition. Using
the human exon coordinates (Table S1), we retrieved the 46-way
multiz hg19 alignments. Missing sequences were manually added
to the alignment as described above. From this alignment, the
predicted ancestral sequence at the root of the bony vertebrates
was reconstructed using the Prequel package (default parameters)
[53]. Next, we searched for TFBSs in the medaka RR sequences
using the Jaspar database (restricting to the Jaspar core vertebrata,
80% relative profile score threshold) [54] and kept only those
binding sites that are specific to the teleosts and absent from all the
other vertebrate sequences, including the predicted ancestral
reconstruction.
Experimental Methods
Medaka stocks. Medaka (Oryzias latipes) strains CAB and
Heino were kept in closed stocks at EMBL Heidelberg and
University of Heidelberg as described [55]. In short, fish were
maintained in a constant recirculating system at 28uC on a 14 h
light/10 h dark cycle. Pairwise mating was performed and
collected embryos were kept at room temperature until hatched.
Cloning of candidates and enhancer assay. Chromosomal
coordinates and species (assembly) of all cloned and tested
fragments are listed in Table S3. Genomic candidate regions
(extended to a maximum of 200 bp on each side) tested in the
enhancer assay were amplified from genomic DNA of medaka,
inbred CAB strain (extraction described in [56]), mouse (C57BL/6
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milii, kind gift from B. Venkatesh) using standard PCR methods.
For the dock9 mouse and shark exon constructs, only the exon and
200 bp downstream sequence could be cloned. The 200 bp
upstream sequence corresponds to a repeat and could not be
amplified. The deletion-constructs were generated by applying a
PCR-driven ‘‘splicing by overlap extension’’ approach [57]. For
the deletion constructs, in all reporter gene constructs the sequence
corresponding to the human exon (the putative RR) was spliced
and the flanking genomic sequences were fused. Coordinates of
the fused fragments are given in Table S3.
The enhancer assay was performed as described in detail in
[21]. In short, genomic sequences were cloned into a transgenesis-
vector upstream of a zebrafish hsp70 minimal promoter and GFP
reporter gene flanked by I-SceI Meganuclease sites using standard
cloning techniques [58]. The constructs were sequenced in order
to verify the sequence and the orientation of the cloned regions.
Deletions and orthologous constructs were cloned in the same
orientation relative to the reporter gene compared to the RR
constructs. Meganuclease-mediated transgenesis by injection into
one-cell stage medaka embryos (heino or cab strains) was
performed as described in [59]. The hsp70 core promoter triggers
a strong and specific lens expression from stage 28 on [22], and
this feature is used to calculate the percentage of specific
expression (Table S3). Stable transgenic lines for all positive
enhancer constructs were obtained. Images of transient/stable
transgenic embryos were taken using an Olympus MVX10
fluorescence microscope with a Leica DC500 camera or a Leica
SPE confocal microscope (106 dipping lens). Images were
assembled and processed using ImageJ and Adobe Photoshop.
All confocal images displayed are Z-projections of stacks.
Mouse transgenic enhancer assay. The mouse sequences
orthologous to the RR were cloned upstream of the human b-
globin minimal promoter-driven LacZ reporter gene [60]. The
constructs were sequenced in order to verify the sequence and the
orientation of the cloned regions. The sequences were cloned in
the same orientation relative to the reporter gene compared to the
RR constructs. Chromosomal coordinates of the cloned and tested
mouse fragments are listed in Table S3 (column 7). To evaluate
what embryonic developmental stage to test for enhancer activity,
we analyzed the expression pattern of the predicted target gene
and compared those patterns with the enhancer activity of the
RRs: For the ttc29 locus, the medaka enhancer is active in the
retina and optic rectum. The putative target gene for this enhancer
is Pou4f2. The mouse Pou4f2 is expressed in the hindbrain and
retina from E10.5 to after birth [61]. We therefore assayed at
embryonic stage E12.5. For the dock9 locus, the medaka enhancer
is active in the cerebellum. The putative target genes for this
enhancer are Zic2 and Zic5. The mouse Zic2 and Zic5 are
expressed in the hindbrain from stage E10.5 to after birth [61]. We
therefore looked at embryonic stage E12.5. For the ccdc46
RR, the
medaka enhancer is active in the forebrain. The putative target
gene for this enhancer is axin2. The mouse Axin2 is expressed in the
telencephalon at stage 14.5 [61]. We therefore looked at
embryonic stage E14.5.
Generation of transgenic mice and embryo staining were carried
out by Cyagen (Cyagen Bioscience Inc.). The dock9
-exon-mouse
constructresultedineighttransgenicembryoswithtwo lacZpositive
embryos in inconsistent embryonic domains. The ccdc46
-exon-mouse
construct resulted in 11 transgenic embryos with only one lacZ
positive embryo. The ttc29
-exon-mouse construct resulted in six
transgenic embryos with no lacZ positive embryo.
Whole-mount in situ hybridization and double-
fluorescent whole-mount in situ hybridization. Whole
mount in situ hybridization using digoxigenin labelled antisense
RNA probes followed by NBT/BCIP colour detection was
performed as previously described [62]. Template cDNA clones
were obtained from the medaka full-length cDNA expression
library of the Wittbrodt group [62]. The following clones were
used to generate the labelled riboprobes: FOE002-P00099-DPE-
F_B12 (pou4f2, genomic location chr1:22399713-22401052), FOE002-
P00076-DPE-F_B12 (zic2, genomic location chr21:9245812-9248089),
FOE002-P00108-DPE-F_N08 (zic5, genomic location chr21:9252145-
9254638), and FOE002-P00056-DPE-F_H05 (axin2 (1 of 2),g e n o m i c
location chr1:4554420-4565844). For genes without a clone in the
library, template fragments for in vitro transcription were directly
amplified from generated cDNA and cloned into a pTOPO vector
(Invitrogen). Total RNA was extracted from 5-d-old embryos using
TRIZOL (Invitrogen), and reverse transcription was performed using
the Superscript III enzyme (Invitrogen). The following primers were
used to amplify cDNA fragments of the genes ednra (1 of 2) (fwd:
TACAGGGCTGTAGCATCTTGGAGCAG, rev: CGTGTTGA-
CGTTGTTGGGTTCTGG), clybl (fwd: GGTAGAAGAGCTCGC-
AGATGTCTATATG, rev: CTGGCGCAGAAGTCGTCTGAG-
CC), and frmpd1 (fwd: ACAGAGAATCCACTCTCCACGTCT-
ACG, rev: TTGGATTTTGTGCTCTGCAGGGATG). In vitro
transcription to generate antisense riboprobes was performed using
sp6, T3, and T7 RNA polymerases (Roche). Images of whole-mount in
situ hybridizations were taken using a Zeiss Axiophot Microscope with
a Leica DC500 camera.
Double fluorescent in situ hybridization using digoxygenin-
labelled probes against the candidate gene (see above) and a
fluorescein-labelled antisense RNA probe generated against GFP
were performed as described in [62]. The probes were visualized
using Fast Red staining (Roche) and the TSA-Kit (PerkinElmer) as
in [62].
Imaging of double-fluorescent whole-mount in situ hybridiza-
tions was done using a Leica SPE confocal mircroscope with a
106 dipping lens. Images were assembled and processed using
ImageJ and Adobe Photoshop. All confocal images displayed are
Z-projections of stacks. Brightness and contrast were adjusted
uniformly across the entire image.
Supporting Information
Figure S1 Overview of the algorithm to identify RR candidate
regions. Filtering steps to accurately identify scenarios leading to
the appearance of an RR as described in Figure 1B. Homologous
regions of all human coding exons were located on the
stickleback repeat-masked, non-exonic genome using BLASTZ.
Further filtering steps were performed in order to only select
putative RRs. Number of remaining hits after each filtering step
is shown on the right. See Materials and Methods, Computa-
tional Pipeline for more details. The coordinates of the
stickleback blastz hits and the corresponding medaka RR
candidates are listed in Table S1.
(PDF)
Figure S2 The enhancer activity of the RRs in juvenile medaka
fish. In all four cases, the enhancer activity of the RR is
maintained in the fish after hatching with similar expression
domains as in the embryo. (A) ttc29
RR shows activity in the optic
tectum (ot) and retina (re), (B) dock9
RR shows activity in a part of
the cerebellum (ce), (C) ccdc46
RR shows activity in the fore- and
hindbrain, and (D) fam44b
RR shows activity in multiple structures
in the brain. The lens expression in all larvae is attributed to the
activity of the hsp70 minimal promoter (see Materials and
Methods) All larvae are shown in dorsal view, anterior is oriented
De Novo Vertebrate Enhancers
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phores in medaka fish.
(PDF)
Figure S3 Assessment of the enhancer activity of the deletion
constructs. (A–D) Genomic coordinates of the medaka RR
enhancer constructs (green bars) and the deletion constructs, in
which the RR corresponding to the length of the human exon was
removed (blue bars). Expression patterns of the RR enhancer
constructs are shown in Figure 2. (E–H) Deletion of the RR from
the ttc29
RR and dock9
RR constructs lead to a loss of enhancer
activity (E, F), while deletion of the RR from the ccdc46
RR
construct shows a severely altered expression pattern (G). Deletion
of the RR from the fam44b
RR construct shows a similar expression
as the full fam44b
RR construct (H). The lens expression is
attributed to the activity of the hsp70 minimal promoter (see
Materials and Methods). All medaka embryos are shown in dorsal
view, anterior is oriented to the left (stages 29 to 32).
(PDF)
Figure S4 Comparison of the expression of the RR-driven GFP
reporter lines and the in situ expression patterns of the flanking
genes in medaka. (A, C, G) GFP expression driven by the RR in
stable transgenic embryos, stage 32 (A,C) and stage 29 (G). The
lens expression is attributed to the activity of the hsp70 minimal
promoter (see Material and Methods). (B, D, E, F, H) Whole
mount in situ hybridizations performed on wild-type embryos with
a DIG-labelled antisense RNA probe directed against the genes
flanking the RRs. GFP driven by the ttc29
RR and the flanking
gene pou4f2 show expression in the optic tectum (A, B), while
dock9
RR-driven GFP and the flanking genes zic2 and zic5 are
expressed in the cerebellum (C, D, E). The reporter gene under
control of ccdc46
RR shows expression in the forebrain, as well as
axin2 (1 of 2), the gene flanking the ccdc46
RR (G, H). frmpd1 does
not show an overlap with ccdc46
RR-driven GFP expression (F, G).
All medaka embryos are shown in dorsal view, anterior is oriented
to the left.
(PDF)
Figure S5 Assessment of the reading frames and AA alignments
of sequences orthologous to the RR candidates. (A) Assessment of
the reading frame in various species: The RRs and the orthologous
regions of the RRs in various species are retrieved and the frame
equivalent to the human coding frame is scanned for stop codon(s).
As expected (see filtering procedure), the reading frame of all
medaka RRs is disrupted (magenta squares), while an open
reading frame (ORF) is present in all the other species (green
squares). Importantly, an ORF is found in at least one outgroup
species of the teleost/tetrapod lineage (elephant shark or ciona) for
all candidate RRs. The numbers above the squares indicate the
reading frame of the human exon. No homologous coding
sequence for ttc29
RR could be found in medaka and shark. (B)
Amino-acid (AA) alignments of the coding exons corresponding to
the RRs in various species including one out-group species of the
teleost/tetrapod lineage (see Materials and Methods, Bioinfor-
matic Analysis of the Candidate RRs).
(PDF)
Figure S6 Alignments of the medaka RRs to the orthologous
human exon (as reference) and other species and assessment of
selective pressures. The alignments spanning the human exon
coordinates were done by retrieving the 46-way multiz hg19
alignments for selected species. The medaka RRs, medaka coding
exon, and the coding exon of an outgroup species were added to
the initial alignment subsequently (see Materials and Methods,
Bioinformatic Analysis of the Candidate RRs). In the case of
dock9
RR the alignment shown spans the length of the shark coding
part of the exon (shortest coding part). Percentage identity at the
nucleotide (NT) level (blue) and the percentage identity/similarity
at the AA level (red) were calculated between human and the other
sequences. The medaka RRs show a higher identity on the NT
level than on the AA level (red arrow), contrasting with regions in
other species, where the selective pressure is acting on the AA
level. The Ka/Ks ratio between human and the medaka RRs, the
medaka coding exon, and the coding exon of an outgroup species
(ciona for TTC29 or shark for DOCK9 and CCDC46) were
calculated. Higher synonymous amino-acid substitution rates were
found at the coding loci (medaka exon and outgroup species)
compared to the RR loci, indicating the non-coding nature of the
RR candidates.
(PDF)
Figure S7 The number of putative transcription factor binding
sites (TFBSs) is lower in coding exons compared to non-exonic
regions and experimentally validated enhancers. (A) For most
structural classes of transcription factors, a higher number of
putative binding sites is found in medaka non-coding regions
(regions randomly picked and regions directly flanking the coding
exon) than in coding exons, suggesting that coding sequences are
less likely to acquire enhancer function compared to non-coding
sequences. The total number of binding sites found is 21,480 for
the coding exon dataset, 38,840 for the random dataset, and
47,203 for the exon-flanking dataset. (B) The number of binding
sites per 200 bp (S200) tend to be lower for exons compared to
experimentally validated enhancers. Both distributions show an
overlap of only 60% (regulatory potential of exons: 60%). The
S200 of the ccdc46
RR, ttc29
RR, and dock9
RR are also represented.
(C) Conversely, the distribution of S200 of non-coding sequences is
very similar to the enhancers reaching the regulatory potential of
non-coding regions is 95% (C) (see Text S1 for more details).
(PDF)
Figure S8 Predicted TFBSs specific to the teleost RR sequences.
Alignment of the medaka RRs to other teleosts and annotation of
the predicted TFBSs that are specific to the teleost sequences and
absent from all the other vertebrate sequences, including the
predicted ancestral reconstructions.
(PDF)
Figure S9 A mouse conserved p300-bound region flanking the
Ccdc46 exon and its orthologs drive reporter gene expression in the
medaka forebrain. The mouse p300 sequence (light green bar,
upper panel) encompassing the predicted p300-bound enhancer
(orange bar, upper panel [38]) and Ccdc46 exonic sequence
(orthologous to the ccdc46
RR) drives GFP expression in the
forebrain and a domain in the hindbrain (A). The expression
pattern remains unchanged (B) when deleting the exonic sequence
from the construct (blue bar, upper panel). The Ccdc46 exon alone
(dark green bar, upper panel) does not show enhancer activity
(Figure 4B). The elephant shark sequence orthologous to the
mouse p300-bound sequence shows a similar expression pattern as
the mouse p300 sequence (C). A construct containing the medaka
orthologous sequence of the mouse p300-bound region (orange
bar, lower panel) also shows enhancer activity in the forebrain and
parts of the optic tectum, hindbrain, and rhombic lips (D). For
clarity we included the coordinates of the ccdc46
RR and the
ccdc46
RR delta RR constructs (dark green and blue bars, lower
panel) previously assayed (Figure 2C and Figure S3C,G). The
genomic coordinates of the tested constructs are given in Table S3.
(PDF)
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corresponds to the gene lost and replaced by a predicted RR in
fish. The genomic coordinates correspond to the human exon
(GRCh37), the stickleback (BROAD S1) BLASTZ hit of the
computational pipeline, and the experimentally validated medaka
RR (MEDAKA1). To calculate the pairwise identity, the number
of identical nucleotides was divided by the length of the shortest
sequence.
(PDF)
Table S2 List of the genes kept in synteny between human and
fish and ciona EST IDs. The human gene ID corresponds to the
gene lost and replaced by the predicted RR in fish. The syntenic
genes are genes which are kept in synteny between human and
fish; in bold are those genes with a developmental GO annotation
(see Material and Methods). The EST IDs in ciona intestinalis are
listed in the last column.
(PDF)
Table S3 Injection statistics of the reporter constructs. For each
construct (column 1) we recorded the number of injected embryos
(column 2), the number of embryos showing GFP expression in the
lens indicative of the successful genomic integration of the
construct (column 3), and the number of embryos showing GFP
expression specific to the enhancer (expression outside the lens,
column 4). From the values of column 3 and 4 the percentage of
specific expression due to the activity of the enhancer is calculated
(column 5). Columns 6 and 7 indicate the genomic coordinates of
the tested regions and the corresponding assembly, respectively.
The enhancer constructs include the extended RR region, while in
the delta RR constructs the region corresponding to the human
exon was deleted (Materials and Methods and Figure S3). The
p300 constructs are described in Figure S9 and the main text.
(PDF)
Text S1 Estimation of the number of de novo enhancers across
the genome.
(DOC)
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